Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q50824517)
Watch
English
(R,R)-asenapine
chemical compound
In more languages
edit
Statements
instance of
type of chemical entity
0 references
subclass of
5-chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole
0 references
has use
medication
0 references
mass
285.092041812
dalton
1 reference
based on heuristic
inferred from SMILES
stereoisomer of
(S,S)-asenapine
2 references
based on heuristic
inferred from InChIKey
based on heuristic
inferred from InChI
chemical formula
C₁₇H₁₆ClNO
0 references
canonical SMILES
CN1CC2C(C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24
1 reference
stated in
PubChem
PubChem CID
3036780
retrieved
26 April 2018
title
Asenapine
(English)
isomeric SMILES
CN1C[C@@H]2[C@@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24
1 reference
stated in
PubChem
PubChem CID
3036780
retrieved
26 April 2018
title
Asenapine
(English)
medical condition treated
bipolar I disorder
start time
13 August 2009
approved by
Food and Drug Administration
1 reference
stated in
Inxight: Drugs Database
retrieved
2 November 2018
reference URL
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022117s010lbl.pdf
schizophrenia
start time
13 August 2009
approved by
Food and Drug Administration
1 reference
stated in
Inxight: Drugs Database
retrieved
2 November 2018
reference URL
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022117s010lbl.pdf
significant drug interaction
aripiprazole
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
apomorphine
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
apomorphine
side effect
long QT syndrome
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
aripiprazole
side effect
long QT syndrome
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
Identifiers
InChI
InChI=1S/C17H16ClNO/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19/h2-8,14-15H,9-10H2,1H3/t14-,15-/m0/s1
1 reference
stated in
PubChem
PubChem CID
3036780
retrieved
26 April 2018
title
Asenapine
(English)
InChIKey
VSWBSWWIRNCQIJ-GJZGRUSLSA-N
2 references
stated in
PubChem
PubChem CID
3036780
retrieved
26 April 2018
title
Asenapine
(English)
stated in
ChEBI release 2020-09-01
ChemSpider ID
2300725
0 references
PubChem CID
3036780
1 reference
stated in
PubChem
PubChem CID
3036780
retrieved
26 April 2018
title
Asenapine
(English)
ChEBI ID
71256
mapping relation type
exact match
0 references
ChEMBL ID
CHEMBL1201756
0 references
SureChEMBL ID
SCHEMBL114123
1 reference
based on heuristic
inferred from InChIKey
UniChem compound ID
155933
1 reference
stated in
UniChem
DSSTox substance ID
DTXSID8049048
0 references
DSSTOX compound identifier
DTXCID3028974
0 references
RxNorm ID
784649
0 references
Probes And Drugs ID
PD013086
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
